Cumberland Pharmaceuticals Inc. Share Price & Technical Analysis
CPIX · $5.87 (+6.53%)
Healthcare / Drug Manufacturers - Specialty & Generic
$5.87
+6.53%
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso,…
Price chart
Seasonality
May has 2 positive and 2 negative years (last 5 years shown)
40% return in May, 0% avg return in past 3 year May month.
57% return in 2026, 61% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -5% | 29% | -35% | 27% | 40% | – | – | – | – | – | – | – | 57% |
| 25 | -4% | 123% | -14% | 14% | 6% | -35% | 6% | 3% | -9% | -3% | -23% | 74% | 137% |
| 24 | 17% | 0% | -23% | -6% | 0% | 0% | -7% | 0% | -7% | -8% | 27% | 71% | 65% |
| 23 | 23% | -15% | -13% | -15% | -6% | -6% | 0% | 7% | 12% | 5% | -16% | 6% | -18% |
| 22 | -28% | -9% | -10% | -21% | -9% | 0% | 10% | 0% | 4% | 0% | 0% | 0% | -62% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Strong
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H. pylori infection. It also develops ifetroban, a product candidate that has completed Phase II clinical trials for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy, hepatorenal syndrome, portal hypertension, aspirin-exacerbated respiratory disease, systemic sclerosis, and idiopathic pulmonary fibrosis. It serves hospital acute care, gastroenterology, and oncology markets in the United States, China, South Korea, Russia, Mexico, Australia, and Saudi Arabia. The company has a strategic alliance agreement with WinHealth Pharma Group Co. Limited. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$67.72M
P/E ratio
—
52W high
$6.27
52W low
$1.85
Volume
1,18,381
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Cumberland Pharmaceuticals Inc. share price today?
- Cumberland Pharmaceuticals Inc. (CPIX) last traded around $5.87 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CPIX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CPIX. Download the app for real-time alerts.
- How can I analyze Cumberland Pharmaceuticals Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.